LY2599506

LY2599506 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY2599506, covering 2011-10-26 to 2011-10-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus [Phase 2]